Shandong Cancer Hospital And Institute
Clinical trials sponsored by Shandong Cancer Hospital And Institute, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New combo therapy aims to shrink liver tumors in hard-to-treat colorectal cancer Results expected Oct 2026 (estimated)
- New combo therapy aims to outsmart 'Cold' rectal tumors Results expected Nov 2026 (estimated)
- New study aims to decode HER2+ breast cancer for personalized treatment Results expected Dec 2026 (estimated)
- Can a radioactive 'Smart Bomb' target tough tumors? Results expected May 2027 (estimated)
- New radiation method aims to boost tumor fight in sarcoma patients Results expected May 2027 (estimated)
-
New radiation boost may improve rectal cancer treatment
Disease control OngoingThis study tests whether giving a higher, targeted radiation dose to the main tumor and nearby lymph nodes can improve outcomes for people with locally advanced rectal cancer. About 128 adults whose cancer has not spread beyond the pelvis will receive either standard radiation or…
Phase 3 • Sponsor: Shandong Cancer Hospital and Institute • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New combo aims to stall lung cancer when targeted pills start to fail
Disease control OngoingThis phase II trial tests whether adding ivonescimab (an immunotherapy drug) to the current targeted therapy pill can help people with advanced non-small cell lung cancer whose disease is slowly progressing. The study involves 36 adults with a specific EGFR gene mutation. Researc…
Phase 2 • Sponsor: Shandong Cancer Hospital and Institute • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Promising combo takes aim at Hard-to-Treat pancreatic cancer
Disease control OngoingThis Phase 2 trial tests a chemotherapy regimen called NALIRIFOX combined with precise radiation (SBRT) in 42 people with locally advanced pancreatic cancer that cannot be removed by surgery. The goal is to see if this approach can delay cancer growth and improve survival. Partic…
Phase 2 • Sponsor: Shandong Cancer Hospital and Institute • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New radiation approach targets tough pancreatic tumors
Disease control PausedThis early-phase study tests a new type of radiation therapy (SCART) for people with locally advanced pancreatic cancer that cannot be removed by surgery. The goal is to find the highest safe dose that can destroy the tumor while protecting nearby organs. About 24 participants wi…
Phase 1 • Sponsor: Shandong Cancer Hospital and Institute • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC